Breaking News
DOJ Signs Cannabis into Schedule III
WASHINGTON – Today, the federal government took its most consequential ...
Cannabis Deals Multiply and Shrink in Q3 2026, Viridian Finds
LOS ANGELES – The Viridian Cannabis Deal Tracker counted 74 ...
AJNA Biosciences Files for DEA Authorization to Grow Cannabis Under FDA Drug Framework
LITTLETON – AJNA Biosciences, a botanical drug development company, applied ...
UN Approves WHO Recommendation On Rescheduling Medical Cannabis
In a move that could have a massive impact on marijuana reform efforts worldwide, the United Nations Commission on Narcotic Drugs (CND) has accepted a recommendation put forth by the World Health Organization (WHO) to ...
Germany’s Medical Cannabis Market Is Becoming a Global Supply Opportunity
LOS ANGELES- Germany’s medical Cannabis market offers North American producers an opportunity that exists today: supplying prescription products through an established pharmaceutical channel. Its significance lies in the combination of rising imports, regulated distribution and ...
Curaleaf Refuses to Back Down
STAMFORD – One day after the Alberta Securities Commission (ASC) dismissed Curaleaf's application to shut down Aurora Cannabis's at-the-market (ATM) share issuance program, Curaleaf Holdings pushed back with a firm statement, insisting the ruling changes ...
Cannabis Users Trust Dispensary Staff Over Doctors, Federal Study Finds
LOS ANGELES – People who use Cannabis trust dispensary staff more than healthcare providers or government agencies for information about the substance, according to a study published in the journal Drugs: Education, Prevention and Policy. ...
